Carlos E. Araujo

Impact of CD34 Cell Dose and Conditioning Regimen on Outcomes after Haploidentical Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Relapsed/Refractory Severe Aplastic Anemia

Leonardo Javier Arcuri, Samir Nabhan, Renato Cunha et al. · Biology of Blood and Marrow Transplantation · 2020 · 48 citations

Medicine, Hematology, Immunology +17

Tumor Regression of Advanced Carcinomas Following Intra-and/or Peri-Tumoral Inoculation with VRCTC-310 in Humans: Preliminary Report of Two Cases

L.A. Marques Da Costa, Horacio A. Miles, Carlos E. Araujo et al. · Immunopharmacology and Immunotoxicology · 1998 · 38 citations

Medicine, Oncology, Pharmacology +16

Ifosfamide and Mesna for the Treatment of Advanced Squamous Cell Head and Neck Cancer

Juan C. Cervellino, Carlos E. Araujo, Claudia Pirisi et al. · Oncology · 2009 · 33 citations

Medicine, Oncology, Radiation Oncology +13

Phase I study of VRCTC-310, a purified phospholipase A2 purified from snake venom, in patients with refractory cancer: safety and pharmacokinetic data

L.A. Marques Da Costa, Horacio A. Miles, Roberto A. Díez et al. · Anti-Cancer Drugs · 1997 · 25 citations

Medicine, Oncology, Pharmacology +14

Treatment of ifosfamide-induced urothelial toxicity by oral administration of sodium 2-mercaptoethane sulphonate (MESNA) to patients with inoperable lung cancer

Carlos E. Araujo, José Tessler · European Journal of Cancer and Clinical Oncology · 1983 · 24 citations

Medicine, Oncology, Pharmacology +9